FDA Approved: TASCENSO ODT — Supplemental Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

FDA granted approval of a supplemental application for TASCENSO ODT, adding fingolimod lauryl sulfate as a new orodispersible tablet formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)

Snippet

SUPPL AP for TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)